Effectiveness and safety of prenatal phenobarbital for the prevention of neonatal jaundice

Pediatric Research

Volumn 14, Issue 8, 1980, Pages 947-952

  Valaes, T ^a   Kipouros, K ^a   Petmezaki, S ^a   Solman, M ^a   Doxiadis, S A ^a  

^a Institute of Child Health   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MENADIONE; PHENOBARBITAL; PLACEBO;

AUDITORY SYSTEM; BLOOD AND HEMOPOIETIC SYSTEM; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HEARING IMPAIRMENT; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN JAUNDICE; ORAL DRUG ADMINISTRATION; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVENTION; PROPHYLAXIS;

BILIRUBIN; CHILD; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INTELLIGENCE; JAUNDICE, NEONATAL; MALE; NERVOUS SYSTEM; PHENOBARBITAL; PREGNANCY;

EID: 0018972970     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/00006450-198008000-00011     Document Type: Article

References (37)

1. Alagille, D., Odièvre, M., Houllemare, L., Viterbo, G., and Leroy, D.: Avitami nose K neonatale severe chez 2 enfants nes de mere traitee par des anticomi- tiaux. Arch. Fr. Pediatr., 25: 31 (1968).
2. Arias, I., Gartner, L. M., Cohen, M., BenEzzer, Y., and Levi, A. J.: Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Am. J. Med. 47: 395 (1969).
3. Beery, K. E., and Buktenica, N. A.: Developmental test of visual-motor integration. (Follett Educational Corporation, Chicago. 1967).
4. Cashore, W. J., Horwich, A., Karotkin, E. H., and Oh, W.: Influence of gestational age and clinical status on bilirubin-binding capacity in newborn infants. Am. J. Dis. Child., 131: 898 (1977).
5. Catz, C., and Yaffé, S. J.: Barbiturate enhancement of bilirubin conjugation and excretion in young and adult animals. Pediatr. Res., 2: 361 (1968).
6. Crigler, J. F., and Gold, N. I.: Sodium phenobarbital-induced decrease in serum bilirubin in an infant with congenital nonhemolytic jaundice and kernicterus. J. Clin. Invest. 45: 998 (1966).
7. Doxiadis, S. A., Valaes, T., Karaklis, A., and Stavrakakis, D.: Risk of severe jaundice in glucose-6-phosphate dehydrogenase deficiency of the newborn. Differences in population groups. Lancet. 2: 1210 (1964).
8. Gartner, L. M., Lee, K. S., Vaisman, S., Lane, D., and Zarafu, I.: Development of bilirubin transport and metabolism in the newborn rhesus monkey. J. Pediatr., 90: 513 (1977).
9. Gartner, L. M., Snyder, R. N., Chadon, R. S., and Bernstein, J.: Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics, 45: 906 (1970).
10. Georgas, J.: The Georgas Intelligence Test for children. (Kedros, Athens, 1971).
11. Goodenough, F. L.: Measurement of intelligence by drawings. (World Book Co. Chicago, 1926).
12. Halpin, T. F., Jones, A. R., Bishop, H. L., and Lerner, S.: Prophylaxis of neonatal hyperbilirubinemia with phenobarbital. Obstet. Gynecol., 40: 85 (1972).
13. Johnson, L., and Boggs, T. R.; Bilirubin-dependent brain damage: incidence and indications for treatment. In: B. G. Odell, R. SchafTer. A. P. Simopoulos: Phototherapy in the Newborn: an Overview, p. 122 (National Academy of Sciences, Washington, D. C., 1974).
14. Kapitulnik, J., Valaes, T., Kaufmann, N. A., and Blondheim, S. H.: Clinical evaluation of Sephadex gel filtration in estimation of bilirubin binding in serum in neonatal jaundice. Arch. Dis. Child., 49: 886 (1974).
15. Kohler, H. G.: Haemorrhage in the newborn of epileptic mothers. Lancet, 1: 267 (1966).
16. Kreek, M. J., and Sleisenger, M. H.: Reduction of serum-unconjugated-bilirubin with phenobarbitone in adult congenital nonhaemolytic unconjugated hyperbilirubinemia. Lancet, 2: 73 (1968).
17. Malloy, H. T., and Evelyn, K. A.: The determination of bilirubin with the photoelectric colorimeter. J. Biol. Chem., 119: 481 (1937).
18. Maurer, H. M., Wolff, J. A., Finster, M., Poppers, P. J., Pantuck, E., Kuntzman, R., and Conney, A. H.: Reduction in concentration of total serum-bilirubin in offspring of women treated with phenobarbitone during pregnancy. Lancet, 2: 122 (1968).
19. Motulsky, A. G., and Campbell-Kraut, J. M.: Population genetics of glucose-6-phosphate dehydrogenase deficiency of the red cell. In: B. S. Blumberg: Proceedings of the Conference on Genetic Polymorphism and Geographic Variations in Disease, p. 159 (Grune & Stratton, New York, 1961).
20. Mountain, K. R., Hirsh, J., and Gallus, A. J.: Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet, 1: 265 (197).
21. Niswander, K. R., and Jordan, M. (Eds.): The collaborative perinatal study of NINDB. (W. B. Saunders Co., Philadelphia, 1972).
22. Odell, G. B., Storey, G. N. B., and Rosenberg, L. A.: Studies in kernicterus. III. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J. Pediatr., 76: 12 (1970).
23. Rainboer, C., Thomson, R. P. H., and Williams, R.: Controlled trials of phenol barbitone therapy in neonatal juandice. Lancet, 1. 966 (1969).
24. Scheit, P. C., Mellits, E. D., Hardy, J. B., Drage, J. S., and Boggs, T. R.: Toxicity to bilirubin in neonates: infant development during first year in relation to maximum neonatal serum bilirubin concentrations. J. Pediatr., 91: 293 (1977).
25. Stem, L., and Denton, R.: Kernicterus in small premature infants. Pediatrics. 35: 483 (1965).
26. Thomas, C. R.: Routine phenobarbital for prevention of neonatal hyperbilirubinemia. Obstet. Gynecol., 47: 304 (1976).
27. Thomas, C. R.: Phenobarbital prophylaxis of neonatal hyperbilirubinemia. Obstet. Gynecol., 50: 607 (1977).
28. Touwen, B. C. L., and Prechtl, H. F. R.: The neurological examination of the child with minor nervous dysfunction. Clinics in Developmental Medicine. Vol. 38 (Heinemann, London, 1971).
29. Triandis, H., Vassiliou, V., and Thomanek, E. K.: Social status as a determinant of respect and friendship acceptance. Sociometry, 29: 396 (1966).
30. Trölle, D.: Phenobarbitone and neonatal icterus. Lancet, 1: 251 (1968).
31. Trölle, D.: Decrease of total serum bilirubin concentration in newborn infants after phenobarbitone treatment. Lancet, 2: 705 (1968).
32. Vaisman, S. L., and Gartner, L. M.: Pharmacologic treatment of neonatal hyperbilirubinemia. Clin. Perinatol. 2: 37 (1975).
33. Valaes, T., Karaklis, A., Stavrakakis, D., Bavela-Stavrakakis, K., Perakis, A., and Doxiadis, S. A.: Incidence and mechanisms of neonatal jaundice related to G- 6-PD deficiency. Pediatr. Res., 3: 448 (1969).
34. Valaes, T., and Petmezaki, S.: Coagulation abnormalities in the neonate after prenatal phenobarbital exposure. Iatriki, 24: 325 (1973).
35. Valaes, T., Petmezaki, S., and Doxiadis, S. A.: Effect on neonatal hyperbilirubinemia of phenobarbital during pregnancy or after birth: practical value of the treatment in a population with high risk of unexplained severe neonatal jaundice. In: Bilirubin Metabolism in the Newborn. Birth Defects, Original Article Series. The National Foundation, March of Dimes. 6: 46 (1970).
36. Wilson, J. T.: Phenobarbital.in the perinatal period. Pediatrics, 43: 324 (1969).
37. Yaffé, S. J., Levy, G., Matsuzawa, T., and Baliah, T.: Enhancement of glucuro-nide conjugating capacity in a hyperbilirubinemic infant due to apparent enzymic induction by phenobarbital. N. Engl. J. Med., 275: 1461 (1966).